Recalls Archives - PharmaLive

U.S. to allow temporary rise in impurities in anti-smoking drug

Blockbusters, Business, Cancer, Distribution, FDA, Impurities, Pfizer, Recalls, Smoking Cessation

The U.S. drug regulator said on July 16 the FDA will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc. halted distribution of the company’s Chantix branded varenicline.

July 16, 2021/by Andrew Humphreys

The Best Defense is a Good Quality Offense

Arthritis, Data Collection, Lawsuits, Manufacturing, Pharma, Recalls, Therapeutics

While data help manufacturers fix plant-floor problems and trace quality issues to their source, it also can prevent recalls. Why not proactively use data to attain an end-to-end view of operations so that product quality can be ensured while reducing recalls?

June 1, 2017/by Administrator